Overview
Zhexu Dong practices practicing medicine in Chengdu, China.
Their clinical expertise encompasses Familial Colorectal Cancer, Colorectal Cancer, Colitis, and Lung Metastases.
They are actively involved in clinical research, co-authoring 11 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Zhexu Dong
Is Zhexu Dong a top-rated expert for Familial Colorectal Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Zhexu Dong is classified as an Experienced expert for Familial Colorectal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Zhexu Dong participate in research or clinical trials?
Yes. Zhexu Dong has published 11 articles and abstracts on conditions like Familial Colorectal Cancer. You can view a list of Zhexu Dong's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ColitisDong isExperienced. Learn about Colitis.
- Colorectal CancerDong isExperienced. Learn about Colorectal Cancer.
- Familial Colorectal CancerDong isExperienced. Learn about Familial Colorectal Cancer.
- Lung MetastasesDong isExperienced. Learn about Lung Metastases.